Table 4 Estimated percentages of broad-spectrum antibiotic prescription in ambulatory carea
From: Cost of inappropriate antimicrobial use for upper respiratory infection in Japan
Class | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|
Third-generation cephalosporins | 13·17 (13·14–13·21) | 13·0 (12·97–13·04) | 12·41 (12·38–12·44) | 11·33 (11·29–11·36) |
Macrolides | 11·06 (11·02–11·09) | 10·56 (10·53–10·59) | 10·58 (10·55–10·61) | 10·38 (10·35–10·41) |
Fluoroquinolones | 4·60 (4·58–4·62) | 4·45 (4·43–4·47) | 4·55 (4·53–4·57) | 4·23 (4·21–4·26) |